Glycopyrronium Bromide, Formoterol Fumarate Dihydrate — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

1 Completed trials

2 Sponsors

17 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 1

Sponsors using this IMP

2 total

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Phase III 16 countries Astrazeneca AB
TRACkER trial Ended

2023-508300-37-00 Phase IV 1 country General Practitioners Research Institute B.V.

Showing 1–2 of 2 trials